ABBV — AbbVie Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 1551152 ·
Last close
$292.82
Market Cap
$517.59B
52W High
$302.93
52W Low
$188.25
ADV30
5,311,867
Next earnings
2026-10-30

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 16,990,000,000 12,699,000,000 6,723,000,000 3,613,000,000 135,115,000,000 6,569,000,000 141,003,000,000
Mar 2026 15,002,000,000 10,784,000,000 4,734,000,000 695,000,000 136,463,000,000 9,391,000,000 143,075,000,000
Dec 2025 16,618,000,000 12,066,000,000 5,809,000,000 1,816,000,000 133,960,000,000 5,229,000,000 137,188,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$20,089,000,000
Investing CF
$-13,449,000,000
Financing CF
$-1,481,000,000
CapEx
$-1,217,000,000
Dividends Paid
$-12,138,000,000
Buybacks
$-1,506,000,000
EPS Diluted TTM
$5.81
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-16,190,000,000
Inventory
$5,305,000,000
Receivables
$13,509,000,000
ST Investments
$28,000,000
EBIT TTM
$15,793,000,000
Pretax Income TTM
$12,814,000,000
Interest Exp TTM
$2,979,000,000
Analysts
26

Yahoo Snapshot (yfinance, live)

Total Revenue
$66,013,999,104
EBITDA
$31,850,999,808
Free Cash Flow
$17,693,124,608
Enterprise Value
$585,512,321,024
Total Cash
$10,773,999,616
Total Debt
$81,317,003,264
Shares Out
1,767,616,306
Trailing EPS
$5.82
Book Value
$-2.59
ROE
—
ROA
10.7%
Div Yield
2.38%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 61,160,000,000 20,091,000,000 4,226,000,000 133,960,000,000 137,188,000,000 -3,270,000,000 19,030,000,000
Dec 2024 56,334,000,000 11,894,000,000 4,278,000,000 135,161,000,000 131,797,000,000 3,325,000,000 18,806,000,000
Dec 2023 54,318,000,000 13,535,000,000 4,863,000,000 134,711,000,000 124,314,000,000 10,360,000,000 22,839,000,000
Dec 2022 58,054,000,000 18,814,000,000 11,836,000,000 138,805,000,000 121,518,000,000 17,254,000,000 24,943,000,000

TTM Snapshot

Revenues TTM
$64,386,000,000
NetIncome TTM
$6,310,000,000
OpCashFlow TTM
—
Assets (Latest)
$135,115,000,000
Forward EPS
$16.19

Max Pain — expiry 2026-11-27

max pain strike: $287.50 · spot: $286.01 · call oi: 2,970 · put oi: 6,858
Expected Move to 2026-11-27: ±$9.62 (3.37%) — implied range $276.38 – $295.63 · ATM straddle on $285.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —
AZN ASTRAZENECA PLC $282.68B $182.27 —
LLY ELI LILLY & Co $1.26T $1415.55 —

News headlines (Yahoo Finance, 1h cache)

Invest $200,000 in These 5 Dividend Stocks to Fund Your Retirement Income
2026-11-17 16:30 · Yahoo
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
2026-11-17 15:02 · Yahoo
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
2026-11-17 13:00 · Yahoo
AbbVie Is Up 27% in a Year. Barclays Sees Another 14%
2026-11-17 12:53 · Yahoo
iShares Core Dividend Growth (DGRO) Buys $4.2 Million More Apple on Nov. 13
2026-11-17 11:04 · Yahoo
These 3 Dividend Stocks Have Crushed the Market This Year. Here’s Why They Are Still Buys
2026-11-17 00:00 · Yahoo
Ken Griffin Dumps SpaceX, Amazon; Buys ARKK and Bets Big on Marvell
2026-11-18 22:30 · Yahoo
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
2026-11-17 23:47 · Yahoo
Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
2026-11-17 14:15 · Yahoo
Is Lilly Stock's Winning Streak Skill Or Luck?
2026-11-18 15:07 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.